emtricitabine
- Product NDC
- 70518-2906
- 11-digit product format
- 705182906
- Labeler code
- 70518
- Product ID
- 70518-2906_e9eadb4e-659e-dcae-e053-2995a90a0db7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- emtricitabine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA091168
- Marketing category
- ANDA
- Marketing start
- 2020-10-12
- Marketing end
- 0000-00-00
- Substance
- EMTRICITABINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2906-0 | 70518290600 | 4 CAPSULE in 1 BLISTER PACK (70518-2906-0) | 4 capsule | 2020-10-12 | 0000-00-00 | No | No | Current |